The healthcare and life sciences industry has been thrust into a new era by major technological and scientific advances as well as heightened costs, competition, and regulatory pressures. This has put additional strain on business’s existing resource. Boyden’s dedicated healthcare and life science practice has the global resources and network to efficiently deploy senior interim leaders who can help clients adapt to change with agility and emerge stronger.
Countless trends are reshaping the sector, leading health systems and life sciences companies to rethink delivery models, drug development, pharmaceutical supply chains and other established systems. Many are pursuing M&A strategies to keep up with modern advancements. These complexities, compounded by an exodus of talent and retention challenges, have created a highly competitive market.
Boyden brings targeted support to clients experiencing rapid growth, implementing digitisation or AI, reorganising, considering process changes, and other key initiatives. Our interim executives alleviate pressure points, bring projects to successful conclusions, and help ensure ongoing organisational health.
We have a long track record of appointing C-level and senior interim managers in the healthcare and life sciences sector covering a range of disciplines including:
Organisations in public and private healthcare, pharmaceuticals, biotech, medical devices, diagnostics and other subsectors trust Boyden as a reliable resource for interim executives who can make an immediate impact and provide leadership that creates value and supports people.
We share our knowledge of topical issues in special reports, interviews and blogs. If you are interested in a specific topic, please ask your Boyden partner or contact our local office.